Edouard J. Trabulsi

Also affiliated with Einstein Medical Center Philadelphia, Sidney Kimmel Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing”.

Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106821

N/A

0.673DataRank · unranked

13 citations

Heather H. Cheng, Amy Leader, Laura Gross, Tatiana Sanchez Nolasco, Nataliya Byrne +21 more

Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates

JCO Precision Oncology(2024)10.1200/po.23.00362

N/A

0.262DataRank · unranked

3 citations

Henkel Valentine, David Liu, Michael J. Slifker, Costas D. Lallas, Edouard J. Trabulsi +24 more

Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2019.11.418

N/A

0.241DataRank · unranked

4 citations

Robert B. Den, J S Greenspan, Timothy N. Showalter, Jean Hoffman‐Censits, Costas D. Lallas +7 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node positive urothelial carcinoma (INSPIRE)—An ECOG-ACRIN and NRG Collaboration.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps4590

N/A

0DataRank · unranked

0 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

EA8185: Phase II study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), ECOG-ACRIN/nrg collaboration.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps500

N/A

0DataRank · unranked

4 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

The international penile advanced cancer trial (InPACT): The first phase III trial for squamous carcinoma of the penis with regional lymph node metastases.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps7

N/A

0DataRank · unranked

15 citations

Steve Nicholson, Philippe E. Spiess, Lance C. Pagliaro, Nick Watkin, Jim Barber +13 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), an ECOG-ACRIN/NRG collaboration.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4617

N/A

0DataRank · unranked

4 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node positive urothelial carcinoma (INSPIRE), an ECOG-ACRIN/NRG collaboration.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps594

N/A

0DataRank · unranked

0 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

Data from Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer

(2023)10.1158/1078-0432.c.6524048.v1

N/A

0DataRank · unranked

0 citations

Lisa D. Berman-Booty, Matthew J. Schiewer, Stephen J. Ciment, Robert B. Den, Adam P. Dicker +6 more

VPAC targeted optical imaging assay (VPAC assay) of voided urine for management of patients with persistently elevated PSA.

JCO Global Oncology(2023)10.1200/go.2023.9.supplement_1.124

N/A

0DataRank · unranked

0 citations

Edouard J. Trabulsi, E Dale, Vivek Singh, Anupriya Chhabra, Olivia Dahlgren +4 more

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia

BJUI Compass(2024)10.1002/bco2.362

N/A

0DataRank · unranked

3 citations

Vivek S. Tomar, E Dale, Leonard G. Gomella, Charalambos Solomides, Oleksandr Kolesnikov +6 more

PET imaging urothelial bladder cancer: A novel approach.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.443

N/A

0DataRank · unranked

0 citations

Leonard G. Gomella, Sushil Tripathi, Ebru Salmanoğlu, Scott W. Keith, William Kevin Kelly +6 more